Skip to main content

Want a detailed portfolio tracker?

Pharming Group N.V. (PHAR) P/E (2020 - 2026)

Pharming Group N.V. (PHAR) P/E from Dec 23, 2020 to Jul 21, 2026. The TTM Pharming Group N.V. (PHAR) P/E is 73.48. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Pharming Group N.V. (PHAR)

YearP/EChange
202673.48-1.46%
202574.57-201.01%
2024-73.82+92.46%
2023-38.36-223.73%
202231.00-25.09%
202141.38+41.64%
202029.22N/A

Comparison Pharming Group N.V. (PHAR) P/E with competitors

Pharming Group N.V. (PHAR) P/E is 73.48.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-99.99%
ENLVEnlivex Ltd0.07-99.90%
FGENFibroGen Inc0.24-99.67%
CHRSCoherus Biosciences Inc0.85-98.85%
FBIOFortress Biotech Inc0.95-98.71%
ORMPOramed Pharmaceuticals Inc1.50-97.95%
AGENAgenus Inc3.01-95.90%
INVAInnoviva Inc3.15-95.71%
VXRTVaxart Inc3.55-95.17%
CRMDCorMedix Inc3.63-95.06%
CVACCureVac N.V.4.45-93.95%
GLPGGalapagos NV4.86-93.39%
SRPTSarepta Therapeutics Inc4.88-93.36%
ABEOAbeona Therapeutics Inc5.39-92.67%
ABUSArbutus Biopharma Corp5.60-92.39%
ZVRAZevra Therapeutics Inc5.89-91.99%
SPROSpero Therapeutics Inc6.23-91.52%
CGENCompugen Ltd6.31-91.41%
RIGLRigel Pharmaceuticals6.87-90.65%
SLXNSilexion Therapeutics Corp7.30-90.07%
OMEROmeros Corporation9.26-87.40%
AUPHAurinia Pharmaceuticals Inc9.58-86.96%
PLXProtalix BioTherapeutics Inc10.89-85.18%
ACADAcadia Pharmaceuticals Inc11.73-84.04%
TBPHTheravance Biopharma Inc12.26-83.31%
ADMAAdma Biologics Inc12.42-83.10%
HRMYHarmony Biosciences Holdings Inc13.82-81.19%
SABSSAB Biotherapeutics Inc14.14-80.76%
NAGENiagen Bioscience Inc14.82-79.83%
INCYIncyte Corp15.82-78.47%
REGNRegeneron Pharmaceuticals Inc15.86-78.42%
PBYIPuma Biotechnology Inc17.32-76.44%
CPRXCatalyst Pharmaceuticals Inc17.44-76.27%
EXELExelixis Inc17.54-76.13%
TGTXTG Therapeutics Inc18.97-74.19%
MDXGMimedx Group Inc20.55-72.03%
XOMAXOMA Royalty Corp22.87-68.87%
ARGXArgen X SE24.30-66.93%
CTMXCytomX Therapeutics Inc24.82-66.22%
XOMAOXOMA Royalty Corp25.34-65.51%
HALOHalozyme Therapeutics Inc25.62-65.13%
XOMAPXOMA Royalty Corp25.67-65.07%
VRTXVertex Pharmaceuticals Inc27.99-61.90%
RPRXRoyalty Pharma plc - Class A28.69-60.96%
SLNOSoleno Therapeutics Inc29.02-60.51%
ASNDAscendis Pharma A/S30.09-59.06%
LGNDLigand Pharmaceuticals Inc - Class B37.91-48.41%
APLSApellis Pharmaceuticals Inc39.02-46.90%
BMRNBiomarin Pharmaceutical Inc42.21-42.55%
KRYSKrystal Biotech Inc45.34-38.29%
ONCBeiGene Ltd69.54-5.36%
TECHBio-Techne Corp101.96+38.76%
VCELVericel Corp109.92+49.59%
ALNYAlnylam Pharmaceuticals Inc117.96+60.54%
GMABGenmab140.29+90.92%
TLXTelix Pharmaceuticals Ltd162.15+120.67%
CORTCorcept Therapeutics Inc212.86+189.68%